Zhejiang CONBA Pharmaceutical's Q3 Net Profit Falls 18.1% Year on Year
Net profit of China's Zhejiang CONBA Pharmaceutical fell 18.1% year on year in the third quarter, Reuters reported.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Chinese drugmaker Zhejiang CONBA Pharmaceutical Co Ltd said its net profit for the third quarter dropped 18.1% from a year earlier. Reuters reported the figure based on the company's statement.
The brief does not include data on revenue, costs or the reasons behind the decline.
why it matters
The story concerns a single pharmaceutical company, so its impact on broader markets is likely limited. For shareholders it signals lower quarterly profit, but without more detail the cause is hard to assess.
tags
instruments
sources
- Zhejiang CONBA Pharmaceutical Q3 Net Profit Down 18.1% Y/Y — Reuters, 27 October 2026 at 14:03 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗